|
1. Benign intracranial tumours (acustic neuromas, schwannomas, small meningiomas, parasagittal meningiomas, pituitary tumour, AVMs).
2. Solitary (or <3) brain metastasis.
3. Solitary (or <3) lung metastasis.
4. Solitary (or <3) liver metastasis.
5. Small primary lung cancer patient with/without mediastinal nodal disease.
6. Localized prostate cancer.
7. Inoperable pancreatic cancer.
8. Localized inoperable gall bladder cancer.
9. Recurrent head and neck cancer.
10. Residual disease/ boost treatment in nasopharynx/PNS region / head & neck cancer.
11. Solitary bone metastasis.
12. High grade gliomas after recurrence (Hypofractionated RT with minimal PTV margin).
13. Pelvic, abdominal post-treatment residual disease.
14. Post chemotherapy/ radiation therapy residual disease in lymphoma.
| 
